DK190284A - Dopamin-beta-hydroxylase-inhibitorer - Google Patents

Dopamin-beta-hydroxylase-inhibitorer Download PDF

Info

Publication number
DK190284A
DK190284A DK190284A DK190284A DK190284A DK 190284 A DK190284 A DK 190284A DK 190284 A DK190284 A DK 190284A DK 190284 A DK190284 A DK 190284A DK 190284 A DK190284 A DK 190284A
Authority
DK
Denmark
Prior art keywords
dopamine
beta
hydroxylase inhibitors
4alkyl
och3
Prior art date
Application number
DK190284A
Other languages
English (en)
Other versions
DK190284D0 (da
DK162629B (da
DK162629C (da
Inventor
James S Frazee
Carl Kaiser
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK190284D0 publication Critical patent/DK190284D0/da
Publication of DK190284A publication Critical patent/DK190284A/da
Publication of DK162629B publication Critical patent/DK162629B/da
Application granted granted Critical
Publication of DK162629C publication Critical patent/DK162629C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Description

R^ er -H, phenyl eller benzyl, og n er 0-4, eller et farmaceutisk acceptabelt syreadditionssalt eller hydrat deraf, forudsat at når R er -C02H eller -CH2NHCgH5, X er -H, og n er 1, er Y ikke -H, kan anvendes til at inhi-bere DBH-aktivitet i pattedyr.
DK190284A 1983-04-12 1984-04-12 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf DK162629C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48412383 1983-04-12
US06/484,123 US4532331A (en) 1983-04-12 1983-04-12 1-Benzyl-2-aminomethyl imidazole derivatives

Publications (4)

Publication Number Publication Date
DK190284D0 DK190284D0 (da) 1984-04-12
DK190284A true DK190284A (da) 1984-10-13
DK162629B DK162629B (da) 1991-11-25
DK162629C DK162629C (da) 1992-04-13

Family

ID=23922842

Family Applications (3)

Application Number Title Priority Date Filing Date
DK190284A DK162629C (da) 1983-04-12 1984-04-12 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf
DK099791A DK99791A (da) 1983-04-12 1991-05-24 Aralkylimidazol
DK099691A DK99691A (da) 1983-04-12 1991-05-24 Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til deres fremstilling

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK099791A DK99791A (da) 1983-04-12 1991-05-24 Aralkylimidazol
DK099691A DK99691A (da) 1983-04-12 1991-05-24 Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til deres fremstilling

Country Status (12)

Country Link
US (1) US4532331A (da)
EP (1) EP0125783B1 (da)
JP (1) JPS59199678A (da)
AT (1) ATE39686T1 (da)
AU (1) AU575558B2 (da)
CA (1) CA1223598A (da)
DE (1) DE3475905D1 (da)
DK (3) DK162629C (da)
ES (2) ES531552A0 (da)
GR (2) GR79885B (da)
IE (1) IE57234B1 (da)
PT (1) PT78389B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4992459A (en) * 1983-04-12 1991-02-12 Smithkline Beecham Corporation Dopamine-β-hydroxylase inhibitors
EP0149976A3 (de) * 1983-12-30 1986-12-10 Ciba-Geigy Ag Substituierte Imidazole
JPS61110266A (ja) * 1984-11-05 1986-05-28 Omron Tateisi Electronics Co カード発行方法
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
JP2581556B2 (ja) * 1986-05-06 1997-02-12 メレルダウファーマスーティカルズ インコーポレーテッド 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
NZ221427A (en) * 1986-08-18 1990-12-21 Smithkline Beckman Corp 2-mercaptoimidazole derivatives and pharmaceutical compositions
US4761415A (en) * 1986-08-28 1988-08-02 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
US4762850A (en) * 1987-03-24 1988-08-09 Smithkline Beckman Corporation Dopamine-beta-hydroxylase inhibitors
US4859779A (en) * 1987-03-24 1989-08-22 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
US4835154A (en) * 1987-06-01 1989-05-30 Smithkline Beckman Corporation 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
US4839371A (en) * 1987-09-17 1989-06-13 Smithkline Beckman Corporation 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
US4935438A (en) * 1987-12-29 1990-06-19 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
US4876266A (en) * 1987-12-31 1989-10-24 Smithkline Beckman Corporation 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
DK440989A (da) * 1988-09-12 1990-03-13 Smithkline Beecham Corp Dopamin-beta-hydroxylase inhibitorer
US5354867A (en) * 1988-12-06 1994-10-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
JP2568315B2 (ja) * 1989-06-30 1997-01-08 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 縮合環アリール置換イミダゾール
CA2032289A1 (en) * 1989-12-29 1991-06-30 Joseph A. Finkelstein Substituted 5-(alkyl) carboxamide imidazoles
GB9010366D0 (en) * 1990-05-09 1990-06-27 Smith Kline French Lab Medicaments
AU3467493A (en) * 1992-01-27 1993-09-01 Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
US7572921B2 (en) * 2005-04-05 2009-08-11 Boehringer Ingelheim International Gmbh Substituted benzylimidazoles useful for the treatment of inflammatory diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE688585A (da) * 1965-10-21 1967-04-20
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
DE2259627A1 (de) * 1972-12-06 1974-06-12 Hoechst Ag Imidazolyl-(2)-thio-alkansaeureester und verfahren zu ihrer herstellung
JPS5069078A (en) * 1973-01-24 1975-06-09 Yoshitomi Pharmaceutical Shinkinaimidazoorujudotai no seizoho
CA1028331A (en) * 1973-01-24 1978-03-21 Michio Nakanishi Imidazole compounds
FI803127L (fi) * 1979-10-03 1981-04-04 Glaxo Group Ltd Heterocykliska foereningar
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors

Also Published As

Publication number Publication date
IE57234B1 (en) 1992-06-17
IE840875L (en) 1984-10-12
GR79885B (da) 1984-10-31
EP0125783A1 (en) 1984-11-21
DE3475905D1 (en) 1989-02-09
US4532331A (en) 1985-07-30
ES8602686A1 (es) 1985-12-01
EP0125783B1 (en) 1989-01-04
DK99791D0 (da) 1991-05-24
PT78389B (en) 1986-09-15
DK99691D0 (da) 1991-05-24
DK99791A (da) 1991-05-24
PT78389A (en) 1984-05-01
DK190284D0 (da) 1984-04-12
ES8601909A1 (es) 1985-11-01
GR79907B (da) 1984-10-31
JPS59199678A (ja) 1984-11-12
ES539565A0 (es) 1985-11-01
ATE39686T1 (de) 1989-01-15
DK99691A (da) 1991-05-24
DK162629B (da) 1991-11-25
CA1223598A (en) 1987-06-30
DK162629C (da) 1992-04-13
AU575558B2 (en) 1988-08-04
AU2672284A (en) 1984-10-18
ES531552A0 (es) 1985-12-01

Similar Documents

Publication Publication Date Title
DK190284A (da) Dopamin-beta-hydroxylase-inhibitorer
ES8105001A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles, sustituidos en posicion 5 o 6 con un anillo de piridazinona
GB1114069A (en) Benzimidazole derivatives and anthelmintic compositions containing them
ES8204739A1 (es) Un procedimiento para preparar compuestos de cefem
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
YU48105B (sh) Derivati triazola i postupak za njihovo dobijanje
SE9203825L (sv) Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
ES8601911A1 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
DK9185A (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf
ZA804146B (en) 2-alkoxyphenyl-imidazo(4,5-b)pyridines, processes for their proparation, pharmaceutical compositions and use thereof
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
ATE12769T1 (de) Imidazolinderivate.
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
ES458719A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
ES440030A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES2037166T3 (es) Eter de dihidropiridina, procedimiento para su fabricacion y su utilizacion.
DE3068456D1 (en) 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation
GB1480892A (en) 3-nitropyrazole derivatives
JPS5687573A (en) 2-aryl-3-acylthiazolidine derivative
ES449960A1 (es) Un procedimiento para la preparacion de nuevas benzodiacepi-nas.
BR8306505A (pt) Compostos,processo para preparacao dos mesmos,medicamento e uso de tais compostos
ES8202558A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES532179A0 (es) Procedimiento para preparar nuevas semicarbazidas

Legal Events

Date Code Title Description
PBP Patent lapsed